The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era

doi:10.1016/S2666-5247(21)00036-7

. 2021 Apr;2(4):e133-e134.

doi: 10.1016/S2666-5247(21)00036-7. Epub 2021 Feb 19.

The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era

Mohammed Nabil Quraishi^{1

2

3}, Sahida Shabir¹, Susan E Manzoor¹, Christopher A Green^{1

2

4}, Naveen Sharma^{1

2}, Andrew D Beggs^{1

2

3}, Tariq H Iqbal^{1

2

4}

Affiliations

¹ University of Birmingham Microbiome Treatment Centre, Birmingham, UK.
² University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
³ Institute of Cancer and Genomic Sciences, University of Birmingham, UK.
⁴ Institute of Microbiology and Infection, University of Birmingham, UK.

PMID: 33655227
PMCID: PMC7906665
DOI: 10.1016/S2666-5247(21)00036-7

The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era

Mohammed Nabil Quraishi et al. Lancet Microbe. 2021 Apr.

. 2021 Apr;2(4):e133-e134.

doi: 10.1016/S2666-5247(21)00036-7. Epub 2021 Feb 19.

Authors

Mohammed Nabil Quraishi^{1

2

3}, Sahida Shabir¹, Susan E Manzoor¹, Christopher A Green^{1

2

4}, Naveen Sharma^{1

2}, Andrew D Beggs^{1

2

3}, Tariq H Iqbal^{1

2

4}

Affiliations

¹ University of Birmingham Microbiome Treatment Centre, Birmingham, UK.
² University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
³ Institute of Cancer and Genomic Sciences, University of Birmingham, UK.
⁴ Institute of Microbiology and Infection, University of Birmingham, UK.

PMID: 33655227
PMCID: PMC7906665
DOI: 10.1016/S2666-5247(21)00036-7

No abstract available

PubMed Disclaimer

Cited by

Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients.
Mehta N, Wang T, Friedman-Moraco RJ, Carpentieri C, Mehta AK, Rouphael N, Dhere T, Larsen CP, Kraft CS, Woodworth MH. Mehta N, et al. J Clin Microbiol. 2022 Feb 16;60(2):e0016121. doi: 10.1128/JCM.00161-21. Epub 2021 Jun 16. J Clin Microbiol. 2022. PMID: 34133889 Free PMC article. Review.
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial.
Al-Shakhshir S, Quraishi MN, Mullish B, Patel A, Vince A, Rowe A, Homer V, Jackson N, Gyimah D, Shabir S, Manzoor S, Cooney R, Alrubaiy L, Quince C, van Schaik W, Hares M, Beggs AD, Efstathiou E, Rimmer P, Weston C, Iqbal T, Trivedi PJ. Al-Shakhshir S, et al. BMJ Open. 2025 Jan 6;15(1):e095392. doi: 10.1136/bmjopen-2024-095392. BMJ Open. 2025. PMID: 39762111 Free PMC article.
How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation.
Groenewegen B, van Lingen E, Ooijevaar RE, Wessels E, Feltkamp MCW, Boeije-Koppenol E, Verspaget HW, Kuijper EJ, van Prehn J, Keller JJ, Terveer EM; Study Group of the Netherlands Donor Feces Bank. Groenewegen B, et al. PLoS One. 2022 Mar 17;17(3):e0265426. doi: 10.1371/journal.pone.0265426. eCollection 2022. PLoS One. 2022. PMID: 35298520 Free PMC article.
Fungal and bacterial gut microbiota differ between Clostridioides difficile colonization and infection.
Henderickx JGE, Crobach MJT, Terveer EM, Smits WK, Kuijper EJ, Zwittink RD. Henderickx JGE, et al. Microbiome Res Rep. 2023 Dec 6;3(1):8. doi: 10.20517/mrr.2023.52. eCollection 2024. Microbiome Res Rep. 2023. PMID: 38455084 Free PMC article.

References

1. Mullish BH, Quraishi MN, Segal JP. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2018;67:1920–1941. - PubMed
1. Zhang JJ, Dong X, Cao YY. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75:1730–1741. - PubMed
1. Hindson J. COVID-19: faecal-oral transmission? Nat Rev Gastroenterol Hepatol. 2020;17:259. - PMC - PubMed
1. Wu Y, Guo C, Tang L. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020;5:434–435. - PMC - PubMed
1. Green CA, Quraishi MN, Shabir S. Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward. Lancet Gastroenterol Hepatol. 2020;5:531. - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Mullish BH, Quraishi MN, Segal JP. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2018;67:1920–1941. - PubMed

[2] Mullish BH, Quraishi MN, Segal JP. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2018;67:1920–1941. - PubMed

[3] Zhang JJ, Dong X, Cao YY. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75:1730–1741. - PubMed

[4] Zhang JJ, Dong X, Cao YY. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75:1730–1741. - PubMed

[5] Hindson J. COVID-19: faecal-oral transmission? Nat Rev Gastroenterol Hepatol. 2020;17:259. - PMC - PubMed

[6] Hindson J. COVID-19: faecal-oral transmission? Nat Rev Gastroenterol Hepatol. 2020;17:259. - PMC - PubMed

[7] Wu Y, Guo C, Tang L. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020;5:434–435. - PMC - PubMed

[8] Wu Y, Guo C, Tang L. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020;5:434–435. - PMC - PubMed

[9] Green CA, Quraishi MN, Shabir S. Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward. Lancet Gastroenterol Hepatol. 2020;5:531. - PMC - PubMed

[10] Green CA, Quraishi MN, Shabir S. Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward. Lancet Gastroenterol Hepatol. 2020;5:531. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era

Affiliations

The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era

Authors

Affiliations

Similar articles

Cited by

References

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical